Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...

Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that h ...

The prevalence of diabetes has alarmingly increased in both developed and developing countries in recent years. The ...

Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon secretion, in the first evidence of a complex neuroimmune-hormonal circuit.

TIXiMED Inc. ( a clinical-stage pharmaceutical company based on the breakthrough discovery that TXNIP plays an important role in the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Researchers from the Icahn School of Medicine at Mount Sinai in New York have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity-a ...

When tested in primary human beta cells, these molecular glues significantly reduced the toxic effects of glucolipotoxicity, thus preserving beta cell function and identity. This discovery ...

Mitochondria act as cellular power plants, converting nutrients into energy. When these structures fail, cells struggle to ...

Islet cell transplantation is not a new concept ... power of science and innovation to transform lives. With each new ...